NCNMGF
PLRX icon

Nano-Cap New Millennium Growth Fund’s Pliant Therapeutics PLRX Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Hold
275,000
– – 0.24% 94
2026
Q1 		$347K Buy
275,000
+40,000
+17% +$50.5K 0.32% 92
2025
Q4 		$287K Buy
+235,000
New +$353K 0.24% 105

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's PLRX Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 275,000 shares worth $314K. The position accounts for 0.24% of the portfolio, ranked #94.

Nano-Cap New Millennium Growth Fund first reported a position in PLRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $347K in Q1 2026. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 275,000 shares of Pliant Therapeutics worth $314K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up 0.24% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #94 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Pliant Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Nano-Cap New Millennium Growth Fund's Pliant Therapeutics position peaked at $347K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.